Matthew D. F. McInnes

Matthew D. F. McInnes

Auto-generated profile, based on publicly available information

Matthew D. F. McInnes

Department of Radiology, University of Ottawa, ON, Canada

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2018 in JAMA
Verified
Journal Article
Closed access
PDF file
MMMatthew D. F. McInnes
Matthew D. F. McInnes
DMDavid Moher
David Moher
BTBrett D. Thombs
Brett D. Thombs
TMTrevor A. McGrath
Trevor A. McGrath
PBPatrick M. Bossuyt
Patrick M. Bossuyt
BWBrian H. Willis
Brian H. Willis
Importance Systematic reviews of diagnostic test accuracy synthesize data from primary diagnostic studies that have evaluated the accuracy of 1 or more index tests against a reference standard, provide estimates of test performance, allow comparisons of the accuracy of different tests, and facilitate the identification of sources of variability in test accuracy. Objective To develop the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) diagnostic test accuracy guideline as a stand-alone extension of the PRISMA statement. Modifications to the PRISMA statement reflect the specific requirements for reporting of systematic reviews and meta-analyses of diagnostic test accuracy studies and the abstracts for these reviews. Design Established standards from the Enhancing the Quality and Transparency of Health Research (EQUATOR) Network were followed for the development of the guideline. The original PRISMA statement was used as a framework on which to modify and add items. A group of 24 multidisciplinary experts used a systematic review of articles on existing reporting guidelines and methods, a 3-round Delphi process, a consensus meeting, pilot testing, and iterative refinement to develop the PRISMA diagnostic test accuracy guideline. The final version of the PRISMA diagnostic test accuracy guideline checklist was approved by the group. Findings The systematic review (produced 64 items) and the Delphi process (provided feedback on 7 proposed items; 1 item was later split into 2 items) identified 71 potentially relevant items for consideration. The Delphi process reduced these to 60 items that were discussed at the consensus meeting. Following the meeting, pilot testing and iterative feedback were used to generate the 27-item PRISMA diagnostic test accuracy checklist. To reflect specific or optimal contemporary systematic review methods for diagnostic test accuracy, 8 of the 27 original PRISMA items were left unchanged, 17 were modified, 2 were added, and 2 were omitted. Conclusions and Relevance The 27-item PRISMA diagnostic test accuracy checklist provides specific guidance for reporting of systematic reviews. The PRISMA diagnostic test accuracy guideline can facilitate the transparent reporting of reviews, and may assist in the evaluation of validity and applicability, enhance replicability of reviews, and make the results from systematic reviews of diagnostic test accuracy studies more useful.

14 August 2020 in BMJ
Verified
Journal Article
Closed access
PDF file
JSJean-Paul Salameh
Jean-Paul Salameh
PBPatrick M Bossuyt
Patrick M Bossuyt
TMTrevor A McGrath
Trevor A McGrath
BTBrett D Thombs
Brett D Thombs
CHChristopher J Hyde
Christopher J Hyde
MMMatthew D F McInnes
Matthew D F McInnes
Systematic reviews of diagnostic test accuracy (DTA) studies are fundamental to the decision making process in evidence based medicine. Although such studies are regarded as high level evidence, these reviews are not always reported completely and transparently. Suboptimal reporting of DTA systematic reviews compromises their validity and generalisability, and subsequently their value to key stakeholders. An extension of the PRISMA (preferred reporting items for systematic review and meta-analysis) statement was recently developed to improve the reporting quality of DTA systematic reviews. The PRISMA-DTA statement has 27 items, of which eight are unmodified from the original PRISMA statement. This article provides an explanation for the 19 new and modified items, along with their meaning and rationale. Examples of complete reporting are used for each item to illustrate best practices.

1 November 2008 in RadioGraphics
Verified
Journal Article
Closed access
NFNajla Fasih
Najla Fasih
ASAlampady K. Prasad Shanbhogue
Alampady K. Prasad Shanbhogue
DMDavid B. Macdonald
David B. Macdonald
MFMargaret A. Fraser-Hill
Margaret A. Fraser-Hill
DPDemetrios Papadatos
Demetrios Papadatos
MAMostafa Atri
Mostafa Atri
Uterine leiomyomas affect 20%-30% of women older than 35 years. Extrauterine leiomyomas are rarer, and they present a greater diagnostic challenge: These histologically benign tumors, which originate from smooth muscle cells, usually arise in the genitourinary tract (in the vulva, ovaries, urethra, and urinary bladder) but may arise in nearly any anatomic site. In addition, unusual growth patterns may be seen, including benign metastasizing leiomyoma, disseminated peritoneal leiomyomatosis, intravenous leiomyomatosis, parasitic leiomyoma, and retroperitoneal growth. In the presence of such a pattern, a synchronous uterine leiomyoma or a previous hysterectomy for removal of a primary uterine tumor may be indicative of the diagnosis. However, some extrauterine leiomyomas may mimic malignancies, and serious diagnostic errors may result. The most useful modalities for detecting extrauterine leiomyomas are ultrasonography, computed tomography, and magnetic resonance (MR) imaging. The superb contrast resolution and multiplanar capabilities of MR imaging make it particularly valuable for characterizing these tumors, which usually show low signal intensity similar to that of smooth muscle on T2-weighted images. The radiologist's recognition of this and other characteristic features may help steer the clinician toward timely, appropriate management and away from unnecessary, potentially harmful treatment.

1 March 2019 in Gastroenterology
Verified
Journal Article
Closed access
CPChristian B. van der Pol
Christian B. van der Pol
CLChristopher S. Lim
Christopher S. Lim
CSClaude B. Sirlin
Claude B. Sirlin
TMTrevor A. McGrath
Trevor A. McGrath
JSJean-Paul Salameh
Jean-Paul Salameh
MMMatthew D.F. McInnes
Matthew D.F. McInnes

1 September 2015 in Radiology
Verified
Journal Article
Closed access
THTaryn Hodgdon
Taryn Hodgdon
MMMatthew D. F. McInnes
Matthew D. F. McInnes
NSNicola Schieda
Nicola Schieda
TFTrevor A. Flood
Trevor A. Flood
LLLeslie Lamb
Leslie Lamb
RTRebecca E. Thornhill
Rebecca E. Thornhill
To determine the accuracy of texture analysis to differentiate fat-poor angiomyolipoma (fp-AML) from renal cell carcinoma (RCC) on unenhanced computed tomography (CT) images. In this institutional review board-approved retrospective case-control study, patients with AML and RCC were identified from the pathology database: there were 16 patients with fp-AML (no visible fat at unenhanced CT) and 84 patients with RCC. Axial unenhanced CT images were contoured manually by two independent analysts. Texture analysis was performed for each lesion, and reproducibility was assessed. Texture features related to the gray-level histogram, gray-level co-occurrence, and run-length matrix statistics were evaluated. The most discriminative features were used to generate support vector machine (SVM) classifiers. Diagnostic accuracy of textural features was assessed and 10-fold cross validation was performed. Unenhanced CT images for each patient were independently reviewed by two blinded radiologists who subjectively graded lesion heterogeneity on a five-point scale. Differences in area under the receiver operating characteristic curve (AUC) between subjective heterogeneity ratings and textural features were evaluated by using the DeLong method. There was lower lesion homogeneity and higher lesion entropy in RCCs (P ≤ .01). A model incorporating several texture features resulted in an AUC of 0.89 ± 0.04. The average SVM accuracy of textural features ranged from 83% to 91% (after 10-fold cross validation). An optimal subjective heterogeneity rating of 2 or higher was identified as a predictor of RCC for both readers, with no significant difference in AUC between readers (P = .06). Each of the three textural-based classifiers was more accurate than either radiologists' subjective heterogeneity ratings for the models incorporating a subset of the top three textural features (difference in AUC between textural features and subjective visual heterogeneity, 0.25; 95% confidence interval: 0.02, 0.47; P = .03). CT texture analysis can be used to accurately differentiate fp-AML from RCC on unenhanced CT images.

10 October 2017 in Systematic Reviews
Verified
Journal Article
Open access
PDF file
TMTrevor A. McGrath
Trevor A. McGrath
MAMostafa Alabousi
Mostafa Alabousi
BSBecky Skidmore
Becky Skidmore
DKDaniël A. Korevaar
Daniël A. Korevaar
PBPatrick M. M. Bossuyt
Patrick M. M. Bossuyt
MMMatthew D. F. McInnes
Matthew D. F. McInnes
This study is to perform a systematic review of existing guidance on quality of reporting and methodology for systematic reviews of diagnostic test accuracy (DTA) in order to compile a list of potential items that might be included in a reporting guideline for such reviews: Preferred Reporting Items for Systematic Reviews and Meta-Analyses of Diagnostic Test Accuracy (PRISMA-DTA). Study protocol published on EQUATOR website. Articles in full text or abstract form that reported on any aspect of reporting systematic reviews of diagnostic test accuracy were eligible for inclusion. We used the Ovid platform to search Ovid MEDLINE®, Ovid MEDLINE® In-Process & Other Non-Indexed Citations and Embase Classic+Embase through May 5, 2016. The Cochrane Methodology Register in the Cochrane Library (Wiley version) was also searched. Title and abstract screening followed by full-text screening of all search results was performed independently by two investigators. Guideline organization websites, published guidance statements, and the Cochrane Handbook for Diagnostic Test Accuracy were also searched. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Standards for Reporting Diagnostic Accuracy (STARD) were assessed independently by two investigators for relevant items. The literature searched yielded 6967 results; 386 were included after title and abstract screening and 203 after full-text screening. After reviewing the existing literature and guidance documents, a preliminary list of 64 items was compiled into the following categories: title (three items); introduction (two items); methods (35 items); results (13 items); discussion (nine items), and disclosure (two items). Items on the methods and reporting of DTA systematic reviews in the present systematic review will provide a basis for generating a PRISMA extension for DTA systematic reviews.